In two prostate cancer cell lines, LNCaP (high androgen receptor activity, low invasiveness) and PC3 (low androgen receptor activity, highly metastatic), both peptides, Ang II and relaxin 2, induced proliferation, however, greater changes were observed in androgen-dependent cell line. This evidence concerns the gene RLN2 and prostate cancer.